Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
05 2019
Historique:
received: 05 11 2018
revised: 15 11 2018
accepted: 13 01 2019
entrez: 22 4 2019
pubmed: 22 4 2019
medline: 28 3 2020
Statut: ppublish

Résumé

In 2000, a panel of experts published a proposal for the selection of lymph node target volumes for definitive head and neck radiation therapy (Radiother Oncol, 2000; 56: 135-150). Hereunder, this selection is updated and extended to also cover primary sites not previously covered. The lymphatic spread of head and neck cancers into neck lymph nodes was comprehensively reviewed based on radiological, surgical and pathological literature regarding both initial involvement and patterns of failure. Then a panel of worldwide head and neck radiotherapy experts agreed on a consensus for the selection of both high- and low-risk lymph node target volumes for the node negative and the node positive neck. An updated selection of lymph node target volumes is reported for oral cavity, oropharynx, hypopharynx, larynx, nasopharynx, paranasal sinuses, nasal cavity and carcinoma of unknown primary as a function of the nodal staging (UICC 8th edition). The selection of lymph node target volumes for head and neck cancers treated with IMRT/VMAT or other highly conformal techniques (e.g. proton therapy) requires a rigorous approach. This updated proposal of selection should help clinicians for the selection of lymph nodes target volumes and contribute to increase consistency.

Sections du résumé

BACKGROUND AND PURPOSE
In 2000, a panel of experts published a proposal for the selection of lymph node target volumes for definitive head and neck radiation therapy (Radiother Oncol, 2000; 56: 135-150). Hereunder, this selection is updated and extended to also cover primary sites not previously covered.
PATIENTS AND METHODS
The lymphatic spread of head and neck cancers into neck lymph nodes was comprehensively reviewed based on radiological, surgical and pathological literature regarding both initial involvement and patterns of failure. Then a panel of worldwide head and neck radiotherapy experts agreed on a consensus for the selection of both high- and low-risk lymph node target volumes for the node negative and the node positive neck.
RESULTS
An updated selection of lymph node target volumes is reported for oral cavity, oropharynx, hypopharynx, larynx, nasopharynx, paranasal sinuses, nasal cavity and carcinoma of unknown primary as a function of the nodal staging (UICC 8th edition).
CONCLUSIONS
The selection of lymph node target volumes for head and neck cancers treated with IMRT/VMAT or other highly conformal techniques (e.g. proton therapy) requires a rigorous approach. This updated proposal of selection should help clinicians for the selection of lymph nodes target volumes and contribute to increase consistency.

Identifiants

pubmed: 31005201
pii: S0167-8140(19)30023-4
doi: 10.1016/j.radonc.2019.01.018
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Julian Biau (J)

Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Department of Radiation Oncology, Jean Perrin Cancer Center, Clermont-Ferrand, France. Electronic address: Julian.biau@clermont.unicancer.fr.

Michel Lapeyre (M)

Department of Radiation Oncology, Jean Perrin Cancer Center, Clermont-Ferrand, France.

Idriss Troussier (I)

Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Wilfried Budach (W)

Department of Radiation Oncology, University Hospital Düsseldorf, Germany.

Jordi Giralt (J)

Department of Radiation Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.

Cai Grau (C)

Department of Oncology, Aarhus University Hospital, Denmark.

Joanna Kazmierska (J)

Department of Radiation Oncology, Greater Poland Cancer Centre, University of Medical Sciences, Poznan, Poland.

Johannes A Langendijk (JA)

Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, the Netherlands.

Mahmut Ozsahin (M)

Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Brian O'Sullivan (B)

Department of Radiation Oncology, University of Toronto, The Princess Margaret Hospital, Canada.

Jean Bourhis (J)

Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Vincent Grégoire (V)

Radiation Oncology Department, Léon Bérard Cancer Center, Lyon, France. Electronic address: Vincent.gregoire@lyon.unicancer.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH